Notice Of Selection As Meti Project For Establishing Biopharmaceutical Manufacturing Sites To Strengthen Vaccine Production
03/10/2022 08:31
Oct 3 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* NOTICE OF SELECTION AS METI"PROJECT FOR ESTABLISHING
BIOPHARMACEUTICAL MANUFACTURING SITES TO STRENGTHEN VACCINE
PRODUCTION
Source text for Eikon: ID:nTSvc83d3a
Further company coverage: 4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results